Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.2 Increasing prevalence of chronic diseases
3.2.3 Rising demand of personalized medicine
3.2.4 Growing awareness about importance of human microbiomes
3.2.5 Rising funding and investments in microbiome research
3.2.6 Industry pitfalls & challenges
3.2.7 High cost associated with microbiome testing
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Kits and reagents
5.3 Instruments
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 16S rRNA sequencing
6.3 Shotgun metagenomics
6.4 Metatranscriptomics
6.5 Other technologies
Chapter 7 Market Estimates and Forecast, By Sample, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Fecal samples
7.3 Saliva samples
7.4 Skin samples
7.5 Other samples
Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Disease diagnostic
8.2.1 Gastrointestinal disorders
8.2.2 Metabolic disorders
8.2.3 Other disease diagnostics
8.3 Research applications
Chapter 9 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospitals
9.3 Academic and research institutes
9.4 Pharmaceuticals and biotechnology companies
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East and Africa
10.6.1 Saudi Arabia
10.6.2 South Africa
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Becton, Dickinson, and Company
11.2 Biome Technologies plc
11.3 Genetic Analysis AS
11.4 Illumina, Inc.
11.5 Microba Life Sciences Limited
11.6 Micronoma, Inc.
11.7 OraSure Technologies, Inc.
11.8 Oxford Nanopore Technologies plc
11.9 Quantbiome, Inc.
11.10 ViennaLab Diagnostics GmbH
